A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer.
Rothenberg ML, Moore MJ, Cripps MC, Andersen JS, Portenoy RK, Burris HA 3rd, Green MR, Tarassoff PG, Brown TD, Casper ES, Storniolo AM, Von Hoff DD.
Rothenberg ML, et al. Among authors: von hoff dd.
Ann Oncol. 1996 Apr;7(4):347-53. doi: 10.1093/oxfordjournals.annonc.a010600.
Ann Oncol. 1996.
PMID: 8805925
Free article.
Clinical Trial.